The emergency use authorization (EUA) for a traditional herbal formula developed in Taiwan to treat COVID-19, known as Taiwan Chingguan Yihau (NRICM101), will be extended to June 2024, Health Minister Hsueh Jui-yuan (薛瑞元) said Sunday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in CORONAVIRUS
-
Taiwan to shorten COVID-19 vaccine interval to 2 months for high-risk groupsThe Centers for Disease Control (CDC) announced Thursday that the required interval between two COVID-19 vaccine doses for high-risk groups will be shortened from six months to two months, effective next Wednesday.06/06/2025 08:17 PM -
CDC confirms ample supply of COVID-19 drugs, vaccinesThe Centers for Disease Control (CDC) reiterated Sunday that Taiwan has sufficient antiviral medication for COVID-19 patients and emphasized the importance of vaccination, amid concerns raised by public figures.06/01/2025 06:13 PM -
CDC issues COVID-19 warning as Dragon Boat Festival long weekend beginsMembers of the public should not let their guard down on COVID-19 and seek medical help if they experience symptoms that indicate risk of severe infection, the Centers for Disease Control (CDC) said Friday, the first day of the Dragon Boat Festival long weekend in Taiwan.05/30/2025 05:04 PM
Latest
-
Business
Taiwan shares close down 0.43%
03/20/2026 01:53 PM -
Business
EVA Air to upgrade Kaohsiung flights with A330-300 jets from May 20
03/20/2026 01:32 PM -
Business
U.S. dollar down in Taipei trading
03/20/2026 11:31 AM -
Society
Magnitude 4.6 earthquake shakes eastern Taiwan
03/20/2026 11:02 AM -
Society
MLB scout saves drunk woman from drowning in Taitung
03/20/2026 10:54 AM


